Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Thousand Oaks Biopharmaceuticals

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 1
Average round size
info
The average size of a deal this fund participated in
$61M
Portfolio companies 1
Rounds per year 0.25
Lead investments 0
Key employees Soon

Areas of investment

  • Association
  • Non Profit
Summary

Thousand Oaks Biopharmaceuticals appeared to be the Corporate Investor, which was created in 2017. The venture was found in Asia in China. The main office of represented Corporate Investor is situated in the Haimen.

The typical case for the fund is to invest in rounds with 8 participants. The meaningful sponsors for the fund in investment in the same round are Yuce Biological Technology, Shenzhen Capital Group, SDIC Venture Capital.

The fund is constantly included in less than 2 investment rounds annually. Deals in the range of 50 - 100 millions dollars are the general things for fund. The important activity for fund was in 2019.

Among the most popular fund investment industries, there are Non Profit, Association. Among the various public portfolio startups of the fund, we may underline MabPlex International For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Thousand Oaks Biopharmaceuticals:
There are no funds here. If we find new data, we will add it here.
Typical Co-investors
Thousand Oaks Biopharmaceuticals is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Thousand Oaks Biopharmaceuticals:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
BankDhofar Muscat, Muscat, Oman
BGS Venture Canada, Ontario, Toronto
Canon Ball -
Chongda Touzi China, Shanghai
Digital Century Capital New York, New York, United States
First Serve Partners Boca Raton, Florida, United States
Gannett Fleming Camp Hill, Pennsylvania, United States
Innvotec England, London, United Kingdom
MEIF Proof-of-Concept & Early Stage Fund -
PICC Health Insurance Beijing, Beijing Shi, China
Pingheng Ziben China, Jiangsu, Nanjing
Plymouth Growth Partners Ann Arbor, Michigan, United States
Provident Capital Gurgaon, Haryana, India
SDVentures New York, New York, United States
Spok Holdings Springfield, United States, Virginia
tarent AG -
Tourne View Ventures New York, New York, United States
Wealth Club Bristol, England, United Kingdom
WND Ventures California, Redwood City, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

MabPlex International

Association
Non Profit
$61M17 Jan 2019 Fremont, California, United States

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Thousand Oaks Biopharmaceuticals?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 1
Average round size 61M
Rounds per year 0.25
Peak activity year 2019
Lead investments 0
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

MabPlex International

Association
Non Profit
$61M17 Jan 2019 Fremont, California, United States
Crunchbase icon

Content report

The following text will be sent to our editors: